apy and therapy outcomes. Initial monotherapy with Fluoroquinolone has the highest survival cases in all patients with CAP. Initial combination therapy with Betalactam+Aminoglycoside has a better outcomes compared to Betalactam+Fluoroquinolone in patients with severe CAP. Background and Aims: Mycobacterium kansasii (MK) is traditionally considered as the high virulent nontuberculous mycobacteria species. Anti-MK treatments including rifampicin, ethambutol and isoniazid or macrolides were usually effective for MK pulmonary disease (PD), but treatment failure did occur in our clinical practice. We aim to identify the possible association between drug resistance and treatment failure.
Methods: MK isolates from sputum were retrospectively collected at National Taiwan University Hospital from May 2013 to December 2014. MK isolates were identified from traditional biochemical method first, and then were confirmed based on the molecular method with 16S ribosomal RNA gene sequencing. The minimum inhibitory concentrations of several antibiotics for MK were determined by a microdilution assay. Clinical outcomes of MK-PD patients receiving anti-MK treatments were evaluated.
Results: 75 MK isolates from 75 patients were identified by the traditional biochemical method. Among them, the molecular method confirmed the MK identification in 56 isolates. For the antimicrobial susceptibility, the resistance rates of MK isolates were relatively low to rifampicin (2/56; 3.6%), clarithromycin (0/56; 0%) and ciprofloxacin (3/56; 5.4%). However, the MK isolates were highly resistant to ethambutol (44/56; 78.6%).
Among 11 MK-PD patients have received anti-MK treatment including ethambutol, the treatment failure rates tended to be higher in ethambutol resistance group than without (42.9% vs 0%, P = 0.236). Kaplan-Meier curves also showed that the MK-PD patients with ethambutol resistance tended to have higher rates of radiographic progression (P = 0.154) and persistent MK isolation in sputum (P = 0.127) than those without.
Conclusion:
The MK isolates in our hospital were highly resistant to ethambutol and the resistance seemed to have an association with treatment failure to the traditional anti-MK regimen including ethambutol. The number of different novel anti-biofilm peptide candidates was tested against P .aeruginosa, and was found to exhibit an antimicrobial, anti-attachment as well as anti-biofilm activity at concentrations in the low μg/mL range compare with current conventional antibiotics. Confocal laser scanning microscopy and CFU count revealed that peptide treatment inhibited biofilm formation resulting in bio-volume reduction followed by induced disruption of mature biofilms and other chronic virulent factors. Further, peptides significantly reduce the extracellular matrix substance of mature biofilms. Background and Aims: Severe pneumonia is responsible for great mortality and morbidity worldwide, and early-applied effective antibiotics are critical for good prognosis of patients. However, identification of infectious agents in severe pneumonia remains a major challenge. In this study, we aimed to evaluate the potential application of transmission electron microscopy (TEM) in etiologic diagnosis of severe pneumonia via BALF.
Conclusion
Methods: A total of 106 patients diagnosed with severe pneumonia at our hospital were included, and baseline characteristics of these patients were collected. Infectious agents detected by TEM in bronchoalveolar lavage fluid were summarized. Bacterial culture results of lower respiratory tract specimens and serological test results were also assessed.
Results: TEM revealed 74 bacteria, 24 viruses, 16 mycoplasmas and 10 chlamydia in 99 samples (61 samples were mixed infections), while pathogens in 7 samples were not detected, which supported that transmission electron microscopy had a good sensitivity in detecting infectious agents in bronchoalveolar lavage fluid. The detection rate of TEM was significantly higher when compared with bacterial culture or serological tests. Combined use of transmission electron microscopy with other diagnostic techniques significantly improved the detection rate of possible infectious agents in patients with severe pneumonia.
Conclusion:
Our data support that TEM could facilitate the etiologic diagnosis of severe pneumonia via BALF and may consequently increase the opportunity of initial appropriate treatment. Background and Aims: Mycobacterium abscessus complex (MABC) exhibits two distinct morphotypes, which are recognized by the appearances of colonies: smooth morphotypes that express glycopeptidolipid (GPL) and rough morphotypes that exhibit diminished GPL expression on the cell wall. The advantage of testing serum immunoglobulin A (IgA) in the diagnosis of MAC (Mycobacterium avim complex) lung disease with smooth morphotypes has been well known, although the testing for GPL core antigen in patients with MABC lung disease is poorly documented. In this study, we focused on testing GPL core antigen in patients with MABC lung disease and confirmed the relationship between the coinfection in other non-tuberculous mycobacteria species and the colony morphology variant in MABC isolates.
Methods: Patients diagnosed with MABC lung disease between 2012 and 2017 at our hospital were enrolled and divided into group 1 (diagnosed with MABC lung disease with MAC co-infection) and group 2 (diagnosed with MABC lung disease without MAC co-infection).
Results: Of the 33 assessed patients with MABC, 13 were included in group 1 and 20 in group 2. The smooth colony variant was more frequently isolated from patients in group 1 than from patients in group 2 [group 1, 9 (69.2%) vs group 2, 4 (20.0%), P = 0.01]. The serum IgA antibody levels in patients in group 1 was higher than those in Group 2 [5.53 (0.07-17.48) U/ mL and 0.13 (0.00-8.32) U/ mL, respectively, P = 0.02].
Conclusion: Serum IgA antibodies against the GPL core antigens in patients with MABC are greatly affected by both MAC co-infection and colony morphology variant of the MABC isolate. Methods: During 2016, the samples (nasopharyngeal swab) will be collected continuously in the influenza virus infection patients in adult; the virus load will be tested by RT-PCR method; and the clinical information of patients, which mainly is influenza symptom score, will be collected.
Results: A total of 160 influenza patients were recruited in 2016, including 70 cases of influenza A (H1N1) (65 cases were H1N1, 1 case was H3N2 and 4 cases were unclassified) and 90 cases of influenza B. The main clinical features were fever, cough, fatigue and headache. The clinical symptoms of influenza patients gradually decreased after reaching the peak on the second day of onset, while the viral load gradually decreased from the first day of onset, showing a positive correlation. Furthermore, on one hand, compare to influenza B infection, the age of patients in the influenza A infection group (45.5 AE 2.0 vs 40.4 AE 2.3 year, P = 0.034)was high, and the hospitalization rate (53.3% vs 33.0%) was significantly increased. Although the initial viral load of patients in the influenza A was significantly lower than that in the influenza B(3.4 AE 1.5 vs 4.5 AE 0.6 copies), yet the virus shedding time of influenza A patients was no difference. On the other hand, although the high-risk group of patients to begin with viral load was 3.4 AE 1.2 copies, lower than low-risk group (4.8 AE 0.7 copies), yet the high-risk group of virus shedding time (from onset to virus test negative) was 7.3 AE 2.3 days, significantly higher than it in the low-risk group (5.3 AE 0.7 days) (Figure 1 ).
There was significant correlation between the clinical symptoms score and viral load in influenza virus infection patients, however, the severity of clinical features depended on the shedding time of virus.
